Comparison of canagliflozin and teneligliptin on energy intake and body weight in Japanese patients with Type 2 diabetes: a subanalysis of the CANTABILE study
Canagliflozin and teneligliptin have different effects on the dietary status of patients with Type 2 diabetes. Our result suggests that canagliflozin can manage blood glucose without weight gain, even with increased energy intake.
Authors
- Michio Noguchi
- Masahiro Isogawa
- Takumi Hirata (ORCID: https://orcid.org/0000-0003-2899-6762)
- Kiminori Hosoda (ORCID: https://orcid.org/0009-0002-9976-6526)
- Kunihiro Nishimura (ORCID: https://orcid.org/0000-0002-0639-0949)
- Hisashi Makino (ORCID: https://orcid.org/0000-0001-9953-3736)
- Masato Kasahara (ORCID: https://orcid.org/0000-0002-1833-9075)
- Shu Kasama (ORCID: https://orcid.org/0000-0001-8958-2366)
- Yoshihiro Miyamoto (ORCID: https://orcid.org/0000-0002-1337-0508)
- Cheol Son (ORCID: https://orcid.org/0000-0002-7916-0546)
Institutions
- Shiga University of Medical Science (JP)
- Ijinkai Takeda General Hospital (JP)
- National Cerebral and Cardiovascular Center (JP)
- Nara Medical University Hospital (JP)
- Kobe City Nishi-Kobe Medical Center (JP)
- Tokyo Metropolitan Institute of Gerontology (JP)
- Nara Medical University (JP)
Publication Details
- Journal
- BMC Endocrine Disorders
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1186/s12902-024-01690-6
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Mitsubishi Tanabe Pharma Corporation